Last reviewed · How we verify

NCT03375918: CONSULT-BP

COmmuNity-engaged SimULation Training for Blood Pressure Control

Completed NA Results posted Last updated 19 September 2025
What this trial tests

NA trial testing CONSULT-BP Educational Intervention in Hypertension in 118 participants. Completed in 31 January 2024.

Timeline
13 August 2018
Primary endpoint
31 December 2022
31 January 2024

Quick facts

Lead sponsorUniversity of Massachusetts, Worcester
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsequential
Maskingnone
Primary purposehealth services research
Enrollment118
Start date13 August 2018
Primary completion31 December 2022
Estimated completion31 January 2024
Sites4 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Massachusetts, Worcester

Who can join

Eligibility, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Blood Pressure Primary · Control period is 6 months before the intervention and intervention period is up to 6 months after the intervention

Systolic and diastolic blood pressure of patients treated by the participating clinician trainees as reported in the Electronic Medical Record.

Systolic Blood Pressure
GroupValue95% CI
Patients - Pre CONSULT-BP Intervention137.6± 18.6
Patients - Post-Intervention136.4± 18.6
Diastolic BloodPressure
GroupValue95% CI
Patients - Pre CONSULT-BP Intervention82.1± 11.1
Patients - Post-Intervention81.8± 10.8
RELATE Checklist, a Standardized Patient Rating Scale for Bias-Mitigating and Patient-Centered Communication Secondary · During CONSULT-BP session 2 clinician training intervention (simulated standardized patient encounter)

The RELATE (Respect, Empathize, Listen, Ask, Talk, Engage) is a 19-item checklist completed by an informant group of "standardized" patients during a simulated standardized patient encounter to evaluate interaction with the participating clinicians. The RELATE checklist contains 4 factors: Respect (4 items), Empathetic Listening (5 items); Ask and Talk (Inquiry, 6 items), and Engagement in Partnership (4 items). The checklist scores are from 0 to 38, with higher scores reflecting better communication from the perspective of the "standardized" patient.

GroupValue95% CI
Healthcare Trainees32.7± 5.0

Sponsor's own description

The goal of CONSULT-BP is to train early-stage healthcare providers, including residents and nurse practitioner (NP) students, to mitigate providers' bias, improve communication skills, and enhance providers' ability to develop authentic and meaningful therapeutic alliances with patients. The study setting is an academic safety net hospital that serves a large non-White and poor population. The Investigators hypothesize that patients' outcomes (blood pressure levels) will be lower after the training intervention compared with before training (control) periods.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. COmmuNity-engaged SimULation Training for Blood Pressure Control (CONSULT-BP): A study protocol.
    Tjia J, Pugnaire M, Calista J, Esparza N, et al · · 2021 · cited 7× · PMID 33592827 · DOI 10.1097/md.0000000000023680
  2. Mitigating Implicit Bias in Patient-Clinician Communication in Clinical Encounters: Protocol from the COmmuNity-engaged SimULation Training (CONSULT) Trial
    Tjia J, Pugnaire M, Calista J, Esparza N, et al · · 2020 · DOI 10.21203/rs.3.rs-39615/v2

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other University of Massachusetts, Worcester trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03375918.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing